Shield Diagnostics (UK) granted European patent for heart attack test:
This article was originally published in Clinica
Sheild Diagnostics (UK) has been granted a European patent for its test for activated factor XII (AFT). The test, developed in collaboration with the University of Oxford, has potential application in the management of patients at risk of heart attack.
You may also be interested in...
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.
A joint report by the US Government Accountability Office and the National Academy of Sciences slams the FDA for dawdling on final software as a medical device rules.